The explanation of a role of the central sensitization in the refractory disease patients with various type of symptoms and an improvement of the patients' care: The relationship between cranial autonomic symptoms and central sensitization in migraine patients using validated central sensitization inventory.

The relationship between cranial autonomic symptoms and central sensitization in migraine patients using validated central sensitization inventory - The relationship between cranial autonomic symptoms and central sensitization in migraine patients using validated central sensitization inventory

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041603

Enrollment

200

Registered

2020-08-29

Start date

2018-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patients who fulfill International Headache Classification 3rd Edition(beta) criteria of 1.1 Migraine without Aura, 1.2 migraine with Aura, and 1.3 Chronic migraine. 2) Medication overuse headache is eligible 3) Inpatients or outpatients 4) Patients with written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with secondary headache except for medication overuse headache 2) Patients with trigeminal autonomic cephalalgias (TACs)

Design outcomes

Primary

Measure	Time frame
Central sensitization severity level in migraine patients with cranial autonomic symptoms	—

Countries

Japan

Contacts

Public ContactDaisuke DANNO

Tominaga Hospital Headache center, Department of neurology

daisuke_danno@yahoo.co.jp06-6568-1601

Outcome results